Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Drug DiscoveryClinical TrialClinical Development

PUBLISHER: Grand View Research | PRODUCT CODE: 1771463

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1771463

Neurology Clinical Trials Market Size, Share & Trends Analysis Report By Phase, By Study Design, By Indication, By Indication by Study Design, By Indication by Phase, By Value Chain, By Region, And Segment Forecasts, 2025 - 2030

PUBLISHED:
PAGES: 120 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 5950
Printable PDF & Excel (5-User License)
USD 6950
Printable PDF & Excel (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

List of Tables

Neurology Clinical Trials Market Growth & Trends:

The global neurology clinical trials market size is estimated to reach USD 8.42 billion by 2030, registering a CAGR of 6.39% from 2025 to 2030, according to a new report by Grand View Research, Inc. This is largely attributed to big pharma companies conducting innovative trials in neurology, increased government funding from the National Institute of Neurological Disorders and Stroke (NINDS), and the high prevalence of neurological disorders worldwide.

Neuroscience continues to receive a healthy investment. For instance, in November 2022, NRG Therapeutics raised Series A funding of USD 18.3 million for the development of mitochondrial therapeutics to treat neurodegenerative ailments such as amyotrophic lateral sclerosis (ALS) and Parkinson's disease. The adoption of similar initiatives in the future is expected to support market growth.

A significant number of people worldwide suffer from neurological disorders. For instance, as per the statistics from Parkinson's Foundation, every year 60,000 Americans are diagnosed with PD and more than 10 million people are living with the disease around the world. In terms of Epilepsy, the WHO states that more than 65 million people worldwide are affected by it. The disease is most prevalent in low- and middle-income countries, which account for 80.0% of epilepsy cases. A high prevalence of neurological disorders is expected to boost demand for clinical trials and thus support the market.

Neurology is considered as one of the major areas where clinical trials are conducted. As per the Pharma R&D Annual Review, in 2021, Neurology trials were the third area where clinical trials were majorly focused. The Pharma R&D Annual Review stated that for neurology above 2,900 drugs were under trial and in the year 2022 the number of drugs for clinical studies in the area of neurology accounted for more than 3,200 active drugs. An increasing number of drugs entering clinical trials in the area of neurology are expected to support the market in the post-pandemic period.

Neurology Clinical Trials Market Report Highlights:

  • By phase, the phase II segment dominated the market and accounted for a maximum revenue share of 42.14% in 2024. A majority number of neurology clinical trials are currently in Phase 2, this is supporting the segment market.
  • By study design, the interventional segment held the largest market revenue share of in 2024. A high number of neurology clinical trials conducted through this study design type is promoting the growth of the segment market.
  • By indication, the Huntington's disease segment is anticipated to register the significant CAGR over the forecast period. This is largely due to the fact that there is a high demand for the medicines used for Huntington's disease worldwide as there are no medications available for treating this disease.
  • North America dominated the market and accounted for a revenue share of 46.96% in 2024. The rising prevalence of neurological disorders and the presence of a large number of players in clinical trials drive the market in the region. These are some of the key reasons for the high market share.
Show more
Product Code: GVR-4-68038-352-2

Table of Contents

Chapter 1. Research Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Study Design
    • 1.2.2. Indication
    • 1.2.3. Indication by Study Design
    • 1.2.4. Indication by Phase
    • 1.2.5. Value Chain
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information Or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
    • 1.7.2. Parent Market Analysis
  • 1.8. List Of Secondary Sources
  • 1.9. List Of Abbreviations
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Neurology Clinical Trials Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing prevalence of neurological diseases such as Alzheimer disease, epilepsy, and stroke
      • 3.2.1.2. Growing adoption of novel technologies in clinical research
      • 3.2.1.3. Substantial number of CROs providing neurology clinical research services
      • 3.2.1.4. Increasing funding for neurological studies by public organizations
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High cost associated with neurology clinical studies
      • 3.2.2.2. High failure rate coupled with patient dropout issues associated with neurological clinical trials
    • 3.2.3. Market Challenges
    • 3.2.4. Market Opportunities
  • 3.3. Technology Landscape
  • 3.4. Pricing Model Analysis
  • 3.5. R&D Spending Analysis (2018-2024)
  • 3.6. Clinical Trial Volume Analysis, 2024
  • 3.7. Market Analysis Tools
    • 3.7.1. Porter's Five Force Analysis
    • 3.7.2. PESTEL by SWOT Analysis
    • 3.7.3. COVID-19 Impact Analysis

Chapter 4. Neurology Clinical Trials Market: Phase Estimates & Trend Analysis

  • 4.1. Neurology Clinical Trials Market, By Phase: Segment Dashboard
  • 4.2. Neurology Clinical Trials Market, By Phase: Movement Analysis
  • 4.3. Neurology Clinical Trials Market Estimates & Forecasts, By Phase, 2018 - 2030 (USD Million)
  • 4.4. Phase I
    • 4.4.1. Phase I Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Phase II
    • 4.5.1. Phase II Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Phase III
    • 4.6.1. Phase III Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Phase IV
    • 4.7.1. Phase IV Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Neurology Clinical Trials Market: Study Design Estimates & Trend Analysis

  • 5.1. Neurology Clinical Trials Market, By Study Design: Segment Dashboard
  • 5.2. Neurology Clinical Trials Market, By Study Design: Movement Analysis
  • 5.3. Neurology Clinical Trials Market Estimates & Forecasts, By Study Design, 2018 - 2030 (USD Million)
  • 5.4. Interventional
    • 5.4.1. Interventional Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Observational
    • 5.5.1. Observational Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Expanded Access
    • 5.6.1. Expanded Access Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Neurology Clinical Trials Market: Indication Estimates & Trend Analysis

  • 6.1. Neurology Clinical Trials Market, By Indication: Segment Dashboard
  • 6.2. Neurology Clinical Trials Market, By Indication: Movement Analysis
  • 6.3. Neurology Clinical Trials Market Estimates & Forecasts, By Indication, 2018 - 2030 (USD Million)
  • 6.4. Alzheimer's Disease
    • 6.4.1. Alzheimer's Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Depression (MDD)
    • 6.5.1. Depression (MDD) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Parkinson's Disease (PD)
    • 6.6.1. Parkinson's Disease (PD) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Epilepsy
    • 6.7.1. Epilepsy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8. Stroke
    • 6.8.1. Stroke Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.9. Traumatic Brain Injury (TBI)
    • 6.9.1. Traumatic Brain Injury (TBI) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.10. Amyotrophic Lateral Sclerosis (ALS)
    • 6.10.1. Amyotrophic Lateral Sclerosis (ALS) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.11. Huntington's Disease
    • 6.11.1. Huntington's Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.12. Muscle Regeneration
    • 6.12.1. Muscle Regeneration Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.13. Others
    • 6.13.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Neurology Clinical Trials Market: Indication by Study Design Estimates & Trend Analysis

  • 7.1. Neurology Clinical Trials Market, Indication by Study Design: Segment Dashboard
  • 7.2. Neurology Clinical Trials Market, Indication by Study Design: Movement Analysis
  • 7.3. Neurology Clinical Trials Market Estimates & Forecasts, Indication by Study Design, 2018 - 2030 (USD Million)
  • 7.4. Alzheimer's Disease
    • 7.4.1. Alzheimer's Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.2. Alzheimer's Disease Interventional
      • 7.4.2.1. Alzheimer's Disease Interventional Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Alzheimer's Disease Observational
      • 7.4.3.1. Alzheimer's Disease Observational Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. Alzheimer's Disease Expanded Access
      • 7.4.4.1. Alzheimer's Disease Expanded Access Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Depression (MDD)
    • 7.5.1. Depression (MDD) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. Depression (MDD) Interventional
      • 7.5.2.1. Depression (MDD) Interventional Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Depression (MDD) Observational
      • 7.5.3.1. Depression (MDD) Observational Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. Depression (MDD) Expanded Access
      • 7.5.4.1. Depression (MDD) Expanded Access Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Parkinson's Disease (PD)
    • 7.6.1. Parkinson's Disease (PD) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. Parkinson's Disease (PD) Interventional
      • 7.6.2.1. Parkinson's Disease (PD) Interventional Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. Parkinson's Disease (PD) Observational
      • 7.6.3.1. Parkinson's Disease (PD) Observational Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. Parkinson's Disease (PD) Expanded Access
      • 7.6.4.1. Parkinson's Disease (PD) Expanded Access Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Epilepsy
    • 7.7.1. Epilepsy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.2. Epilepsy Interventional
      • 7.7.2.1. Epilepsy Interventional Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.3. Epilepsy Observational
      • 7.7.3.1. Epilepsy Observational Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.4. Epilepsy Expanded Access
      • 7.7.4.1. Epilepsy Expanded Access Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8. Stroke
    • 7.8.1. Stroke Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.2. Stroke Interventional
      • 7.8.2.1. Stroke Interventional Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.3. Stroke Observational
      • 7.8.3.1. Stroke Observational Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.4. Stroke Expanded Access
      • 7.8.4.1. Stroke Expanded Access Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.9. Traumatic Brain Injury (TBI)
    • 7.9.1. Traumatic Brain Injury (TBI) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.9.2. Traumatic Brain Injury (TBI) Interventional
      • 7.9.2.1. Traumatic Brain Injury (TBI) Interventional Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.9.3. Traumatic Brain Injury (TBI) Observational
      • 7.9.3.1. Traumatic Brain Injury (TBI) Observational Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.9.4. Traumatic Brain Injury (TBI) Expanded Access
      • 7.9.4.1. Traumatic Brain Injury (TBI) Expanded Access Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.10. Amyotrophic Lateral Sclerosis (ALS)
    • 7.10.1. Amyotrophic Lateral Sclerosis (ALS) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.10.2. Amyotrophic Lateral Sclerosis (ALS) Interventional
      • 7.10.2.1. Amyotrophic Lateral Sclerosis (ALS) Interventional Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.10.3. Amyotrophic Lateral Sclerosis (ALS) Observational
      • 7.10.3.1. Amyotrophic Lateral Sclerosis (ALS) Observational Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.10.4. Amyotrophic Lateral Sclerosis (ALS) Expanded Access
      • 7.10.4.1. Amyotrophic Lateral Sclerosis (ALS) Expanded Access Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.11. Huntington's Disease
    • 7.11.1. Huntington's Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.11.2. Huntington's Disease Interventional
      • 7.11.2.1. Huntington's Disease Interventional Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.11.3. Huntington's Disease Observational
      • 7.11.3.1. Huntington's Disease Observational Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.11.4. Huntington's Disease Expanded Access
      • 7.11.4.1. Huntington's Disease Expanded Access Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.12. Muscle Regeneration
    • 7.12.1. Muscle Regeneration Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.12.2. Muscle Regeneration Interventional
      • 7.12.2.1. Muscle Regeneration Interventional Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.12.3. Muscle Regeneration Observational
      • 7.12.3.1. Muscle Regeneration Observational Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.12.4. Muscle Regeneration Expanded Access
      • 7.12.4.1. Muscle Regeneration Expanded Access Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.13. Others
    • 7.13.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.13.2. Others Interventional
      • 7.13.2.1. Others Interventional Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.13.3. Others Observational
      • 7.13.3.1. Others Observational Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.13.4. Others Expanded Access
      • 7.13.4.1. Others Expanded Access Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Neurology Clinical Trials Market: Indication by Phase Estimates & Trend Analysis

  • 8.1. Neurology Clinical Trials Market, Indication by Phase: Segment Dashboard
  • 8.2. Neurology Clinical Trials Market, Indication by Phase: Movement Analysis
  • 8.3. Neurology Clinical Trials Market Estimates & Forecasts, Indication by Phase, 2018 - 2030 (USD Million)
  • 8.4. Alzheimer's Disease
    • 8.4.1. Alzheimer's Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.2. Alzheimer's Disease Phase I
      • 8.4.2.1. Alzheimer's Disease Phase I Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.3. Alzheimer's Disease Phase II
      • 8.4.3.1. Alzheimer's Disease Phase II Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.4. Alzheimer's Disease Phase III
      • 8.4.4.1. Alzheimer's Disease Phase III Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.5. Alzheimer's Disease Phase IV
      • 8.4.5.1. Alzheimer's Disease Phase IV Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5. Depression (MDD)
    • 8.5.1. Depression (MDD) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.2. Depression (MDD) Phase I
      • 8.5.2.1. Depression (MDD) Phase I Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.3. Depression (MDD) Phase II
      • 8.5.3.1. Depression (MDD) Phase II Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.4. Depression (MDD) Phase III
      • 8.5.4.1. Depression (MDD) Phase III Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.5. Depression (MDD) Phase IV
      • 8.5.5.1. Depression (MDD) Phase IV Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6. Parkinson's Disease (PD)
    • 8.6.1. Parkinson's Disease (PD) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.2. Parkinson's Disease (PD) Phase I
      • 8.6.2.1. Parkinson's Disease (PD) Phase I Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.3. Parkinson's Disease (PD) Phase II
      • 8.6.3.1. Parkinson's Disease (PD) Phase II Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.4. Parkinson's Disease (PD) Phase III
      • 8.6.4.1. Parkinson's Disease (PD) Phase III Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.5. Parkinson's Disease (PD) Phase IV
      • 8.6.5.1. Parkinson's Disease (PD) Phase IV Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7. Epilepsy
    • 8.7.1. Epilepsy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.2. Epilepsy Phase I
      • 8.7.2.1. Epilepsy Phase I Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.3. Epilepsy Phase II
      • 8.7.3.1. Epilepsy Phase II Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.4. Epilepsy Phase III
      • 8.7.4.1. Epilepsy Phase III Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.5. Epilepsy Phase IV
      • 8.7.5.1. Epilepsy Phase IV Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.8. Stroke
    • 8.8.1. Stroke Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.8.2. Stroke Phase I
      • 8.8.2.1. Stroke Phase I Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.8.3. Stroke Phase II
      • 8.8.3.1. Stroke Phase II Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.8.4. Stroke Phase III
      • 8.8.4.1. Stroke Phase III Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.8.5. Stroke Phase IV
      • 8.8.5.1. Stroke Phase IV Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.9. Traumatic Brain Injury (TBI)
    • 8.9.1. Traumatic Brain Injury (TBI) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.9.2. Traumatic Brain Injury (TBI) Phase I
      • 8.9.2.1. Traumatic Brain Injury (TBI) Phase I Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.9.3. Traumatic Brain Injury (TBI) Phase II
      • 8.9.3.1. Traumatic Brain Injury (TBI) Phase II Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.9.4. Traumatic Brain Injury (TBI) Phase III
      • 8.9.4.1. Traumatic Brain Injury (TBI) Phase III Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.9.5. Traumatic Brain Injury (TBI) Phase IV
      • 8.9.5.1. Traumatic Brain Injury (TBI) Phase IV Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.10. Amyotrophic Lateral Sclerosis (ALS)
    • 8.10.1. Amyotrophic Lateral Sclerosis (ALS) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.10.2. Amyotrophic Lateral Sclerosis (ALS) Phase I
      • 8.10.2.1. Amyotrophic Lateral Sclerosis (ALS) Phase I Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.10.3. Amyotrophic Lateral Sclerosis (ALS) Phase II
      • 8.10.3.1. Amyotrophic Lateral Sclerosis (ALS) Phase II Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.10.4. Amyotrophic Lateral Sclerosis (ALS) Phase III
      • 8.10.4.1. Amyotrophic Lateral Sclerosis (ALS) Phase III Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.10.5. Amyotrophic Lateral Sclerosis (ALS) Phase IV
      • 8.10.5.1. Amyotrophic Lateral Sclerosis (ALS) Phase IV Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.11. Huntington's Disease
    • 8.11.1. Huntington's Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.11.2. Huntington's Disease Phase I
      • 8.11.2.1. Huntington's Disease Phase I Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.11.3. Huntington's Disease Phase II
      • 8.11.3.1. Huntington's Disease Phase II Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.11.4. Huntington's Disease Phase III
      • 8.11.4.1. Huntington's Disease Phase III Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.11.5. Huntington's Disease Phase IV
      • 8.11.5.1. Huntington's Disease Phase IV Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.12. Muscle Regeneration
    • 8.12.1. Muscle Regeneration Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.12.2. Muscle Regeneration Phase I
      • 8.12.2.1. Muscle Regeneration Phase I Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.12.3. Muscle Regeneration Phase II
      • 8.12.3.1. Muscle Regeneration Phase II Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.12.4. Muscle Regeneration Phase III
      • 8.12.4.1. Muscle Regeneration Phase III Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.12.5. Muscle Regeneration Phase IV
      • 8.12.5.1. Muscle Regeneration Phase IV Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.13. Others
    • 8.13.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.13.2. Others Phase I
      • 8.13.2.1. Others Phase I Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.13.3. Others Phase II
      • 8.13.3.1. Others Phase II Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.13.4. Others Phase III
      • 8.13.4.1. Others Phase III Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.13.5. Others Phase IV
      • 8.13.5.1. Others Phase IV Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Neurology Clinical Trials Market: Value Chain Estimates & Trend Analysis

  • 9.1. Neurology Clinical Trials Market, By Value Chain: Segment Dashboard
  • 9.2. Neurology Clinical Trials Market, By Value Chain: Movement Analysis
  • 9.3. Neurology Clinical Trials Market Estimates & Forecasts, By Value Chain, 2018 - 2030 (USD Million)
  • 9.4. In-house
    • 9.4.1. In-house Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.5. CROs
    • 9.5.1. CROs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.6. Investigator Sites/Clinical Sites
    • 9.6.1. Investigator Sites/Clinical Sites Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 10. Neurology Clinical Trials Market: Regional Estimates & Trend Analysis

  • 10.1. Regional Market Dashboard
  • 10.2. Regional Market Share Analysis, 2024 & 2030
  • 10.3. North America
    • 10.3.1. North America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 10.3.2. U.S
      • 10.3.2.1. Key Country Dynamics
      • 10.3.2.2. Competitive Scenario
      • 10.3.2.3. Regulatory Framework
      • 10.3.2.4. U.S. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 10.3.3. Canada
      • 10.3.3.1. Key Country Dynamics
      • 10.3.3.2. Competitive Scenario
      • 10.3.3.3. Regulatory Framework
      • 10.3.3.4. Canada Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 10.3.4. Mexico
      • 10.3.4.1. Key Country Dynamics
      • 10.3.4.2. Competitive Scenario
      • 10.3.4.3. Regulatory Framework
      • 10.3.4.4. Mexico Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 10.4. Europe
    • 10.4.1. Europe Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 10.4.2. UK
      • 10.4.2.1. Key Country Dynamics
      • 10.4.2.2. Competitive Scenario
      • 10.4.2.3. Regulatory Framework
      • 10.4.2.4. UK Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 10.4.3. Germany
      • 10.4.3.1. Key Country Dynamics
      • 10.4.3.2. Competitive Scenario
      • 10.4.3.3. Regulatory Framework
      • 10.4.3.4. Germany Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 10.4.4. France
      • 10.4.4.1. Key Country Dynamics
      • 10.4.4.2. Competitive Scenario
      • 10.4.4.3. Regulatory Framework
      • 10.4.4.4. France Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 10.4.5. Italy
      • 10.4.5.1. Key Country Dynamics
      • 10.4.5.2. Competitive Scenario
      • 10.4.5.3. Regulatory Framework
      • 10.4.5.4. Italy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 10.4.6. Spain
      • 10.4.6.1. Key Country Dynamics
      • 10.4.6.2. Competitive Scenario
      • 10.4.6.3. Regulatory Framework
      • 10.4.6.4. Spain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 10.4.7. Denmark
      • 10.4.7.1. Key Country Dynamics
      • 10.4.7.2. Competitive Scenario
      • 10.4.7.3. Regulatory Framework
      • 10.4.7.4. Denmark Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 10.4.8. Sweden
      • 10.4.8.1. Key Country Dynamics
      • 10.4.8.2. Competitive Scenario
      • 10.4.8.3. Regulatory Framework
      • 10.4.8.4. Sweden Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 10.4.9. Norway
      • 10.4.9.1. Key Country Dynamics
      • 10.4.9.2. Competitive Scenario
      • 10.4.9.3. Regulatory Framework
      • 10.4.9.4. Norway Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 10.5. Asia Pacific
    • 10.5.1. Asia Pacific Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 10.5.2. Japan
      • 10.5.2.1. Key Country Dynamics
      • 10.5.2.2. Competitive Scenario
      • 10.5.2.3. Regulatory Framework
      • 10.5.2.4. Japan Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 10.5.3. China
      • 10.5.3.1. Key Country Dynamics
      • 10.5.3.2. Competitive Scenario
      • 10.5.3.3. Regulatory Framework
      • 10.5.3.4. China Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 10.5.4. India
      • 10.5.4.1. Key Country Dynamics
      • 10.5.4.2. Competitive Scenario
      • 10.5.4.3. Regulatory Framework
      • 10.5.4.4. India Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 10.5.5. Thailand
      • 10.5.5.1. Key Country Dynamics
      • 10.5.5.2. Competitive Scenario
      • 10.5.5.3. Regulatory Framework
      • 10.5.5.4. Thailand Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 10.5.6. South Korea
      • 10.5.6.1. Key Country Dynamics
      • 10.5.6.2. Competitive Scenario
      • 10.5.6.3. Regulatory Framework
      • 10.5.6.4. South Korea Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 10.5.7. Australia
      • 10.5.7.1. Key Country Dynamics
      • 10.5.7.2. Competitive Scenario
      • 10.5.7.3. Regulatory Framework
      • 10.5.7.4. Australia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 10.6. Latin America
    • 10.6.1. Latin America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 10.6.2. Brazil
      • 10.6.2.1. Key Country Dynamics
      • 10.6.2.2. Competitive Scenario
      • 10.6.2.3. Regulatory Framework
      • 10.6.2.4. Brazil Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 10.6.3. Argentina
      • 10.6.3.1. Key Country Dynamics
      • 10.6.3.2. Competitive Scenario
      • 10.6.3.3. Regulatory Framework
      • 10.6.3.4. Argentina Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 10.7. MEA
    • 10.7.1. MEA Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 10.7.2. South Africa
      • 10.7.2.1. Key Country Dynamics
      • 10.7.2.2. Competitive Scenario
      • 10.7.2.3. Regulatory Framework
      • 10.7.2.4. South Africa Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 10.7.3. Saudi Arabia
      • 10.7.3.1. Key Country Dynamics
      • 10.7.3.2. Competitive Scenario
      • 10.7.3.3. Regulatory Framework
      • 10.7.3.4. Saudi Arabia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 10.7.4. UAE
      • 10.7.4.1. Key Country Dynamics
      • 10.7.4.2. Competitive Scenario
      • 10.7.4.3. Regulatory Framework
      • 10.7.4.4. UAE Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 10.7.5. Kuwait
      • 10.7.5.1. Key Country Dynamics
      • 10.7.5.2. Competitive Scenario
      • 10.7.5.3. Regulatory Framework
      • 10.7.5.4. Kuwait Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Show more
Product Code: GVR-4-68038-352-2

List of Tables

  • Table 1. List of Tables
  • Table 2. List of Secondary Sources
  • Table 3. List of Abbreviations
  • Table 4. Global Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
  • Table 5. Global Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
  • Table 6. Global Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 7. Global Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
  • Table 8. Global Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
  • Table 9. Global Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
  • Table 10. Global Neurology Clinical Trials Market Estimates and Forecasts, by Region, 2018 - 2030 (USD Million)
  • Table 11. North America Neurology Clinical Trials Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • Table 12. North America Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
  • Table 13. North America Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
  • Table 14. North America Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 15. North America Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
  • Table 16. North America Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
  • Table 17. North America Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
  • Table 18. U.S. Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
  • Table 19. U.S. Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
  • Table 20. U.S. Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 21. U.S. Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
  • Table 22. U.S. Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
  • Table 23. U.S. Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
  • Table 24. Canada Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
  • Table 25. Canada Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
  • Table 26. Canada Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 27. Canada Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
  • Table 28. Canada Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
  • Table 29. Canada Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
  • Table 30. Mexico Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
  • Table 31. Mexico Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
  • Table 32. Mexico Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 33. Mexico Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
  • Table 34. Mexico Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
  • Table 35. Mexico Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
  • Table 36. Europe Neurology Clinical Trials Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • Table 37. Europe Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
  • Table 38. Europe Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
  • Table 39. Europe Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 40. Europe Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
  • Table 41. Europe Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
  • Table 42. Europe Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
  • Table 43. UK Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
  • Table 44. UK Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
  • Table 45. UK Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 46. UK Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
  • Table 47. UK Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
  • Table 48. UK Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
  • Table 49. Germany Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
  • Table 50. Germany Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
  • Table 51. Germany Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 52. Germany Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
  • Table 53. Germany Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
  • Table 54. Germany Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
  • Table 55. France Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
  • Table 56. France Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
  • Table 57. France Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 58. France Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
  • Table 59. France Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
  • Table 60. France Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
  • Table 61. Italy Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
  • Table 62. Italy Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
  • Table 63. Italy Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 64. Italy Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
  • Table 65. Italy Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
  • Table 66. Italy Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
  • Table 67. Spain Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
  • Table 68. Spain Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
  • Table 69. Spain Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 70. Spain Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
  • Table 71. Spain Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
  • Table 72. Spain Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
  • Table 73. Denmark Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
  • Table 74. Denmark Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
  • Table 75. Denmark Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 76. Denmark Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
  • Table 77. Denmark Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
  • Table 78. Denmark Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
  • Table 79. Sweden Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
  • Table 80. Sweden Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
  • Table 81. Sweden Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 82. Sweden Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
  • Table 83. Sweden Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
  • Table 84. Sweden Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
  • Table 85. Norway Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
  • Table 86. Norway Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
  • Table 87. Norway Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 88. Norway Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
  • Table 89. Norway Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
  • Table 90. Norway Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
  • Table 91. Asia Pacific Neurology Clinical Trials Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • Table 92. Asia Pacific Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
  • Table 93. Asia Pacific Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
  • Table 94. Asia Pacific Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 95. Asia Pacific Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
  • Table 96. Asia Pacific Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
  • Table 97. Asia Pacific Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
  • Table 98. Japan Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
  • Table 99. Japan Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
  • Table 100. Japan Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 101. Japan Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
  • Table 102. Japan Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
  • Table 103. Japan Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
  • Table 104. China Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
  • Table 105. China Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
  • Table 106. China Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 107. China Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
  • Table 108. China Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
  • Table 109. China Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
  • Table 110. India Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
  • Table 111. India Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
  • Table 112. India Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 113. India Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
  • Table 114. India Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
  • Table 115. India Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
  • Table 116. Thailand Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
  • Table 117. Thailand Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
  • Table 118. Thailand Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 119. Thailand Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
  • Table 120. Thailand Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
  • Table 121. Thailand Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
  • Table 122. South Korea Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
  • Table 123. South Korea Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
  • Table 124. South Korea Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 125. South Korea Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
  • Table 126. South Korea Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
  • Table 127. South Korea Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
  • Table 128. Australia Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
  • Table 129. Australia Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
  • Table 130. Australia Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 131. Australia Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
  • Table 132. Australia Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
  • Table 133. Australia Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
  • Table 134. Latin America Neurology Clinical Trials Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • Table 135. Latin America Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
  • Table 136. Latin America Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
  • Table 137. Latin America Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 138. Latin America Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
  • Table 139. Latin America Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
  • Table 140. Latin America Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
  • Table 141. Brazil Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
  • Table 142. Brazil Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
  • Table 143. Brazil Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 144. Brazil Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
  • Table 145. Brazil Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
  • Table 146. Brazil Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
  • Table 147. Argentina Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
  • Table 148. Argentina Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
  • Table 149. Argentina Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 150. Argentina Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
  • Table 151. Argentina Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
  • Table 152. Argentina Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
  • Table 153. Middle East & Africa Neurology Clinical Trials Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • Table 154. Middle East & Africa Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
  • Table 155. Middle East & Africa Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
  • Table 156. Middle East & Africa Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 157. Middle East & Africa Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
  • Table 158. Middle East & Africa Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
  • Table 159. Middle East & Africa Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
  • Table 160. South Africa Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
  • Table 161. South Africa Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
  • Table 162. South Africa Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 163. South Africa Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
  • Table 164. Saudi Arabia Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
  • Table 165. Saudi Arabia Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
  • Table 166. Saudi Arabia Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 167. Saudi Arabia Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
  • Table 168. Saudi Arabia Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
  • Table 169. Saudi Arabia Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
  • Table 170. UAE Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
  • Table 171. UAE Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
  • Table 172. UAE Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 173. UAE Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
  • Table 174. UAE Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
  • Table 175. UAE Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)
  • Table 176. Kuwait Neurology Clinical Trials Market Estimates and Forecasts, by Phase, 2018 - 2030 (USD Million)
  • Table 177. Kuwait Neurology Clinical Trials Market Estimates and Forecasts, by Study Design, 2018 - 2030 (USD Million)
  • Table 178. Kuwait Neurology Clinical Trials Market Estimates and Forecasts, by Indication, 2018 - 2030 (USD Million)
  • Table 179. Kuwait Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Study Design, 2018 - 2030 (USD Million)
  • Table 180. Kuwait Neurology Clinical Trials Market Estimates and Forecasts, by Indication by Phase, 2018 - 2030 (USD Million)
  • Table 181. Kuwait Neurology Clinical Trials Market Estimates and Forecasts, by Value Chain, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Market formulation & validation
  • Fig. 6 Commodity flow analysis
  • Fig. 7 Value-chain-based sizing & forecasting
  • Fig. 8 QFD model sizing & forecasting
  • Fig. 9 Bottom-up approach
  • Fig. 10 Market snapshot
  • Fig. 11 Segment snapshot 1
  • Fig. 12 Segment snapshot 2
  • Fig. 13 Competitive landscape snapshot
  • Fig. 14 Parent market outlook, 2024 (USD Billion)
  • Fig. 15 Ancillary market outlook, 2024 (USD Billion)
  • Fig. 16 Neurology Clinical Trials Market Dynamics
  • Fig. 17 Porter's five forces analysis
  • Fig. 18 PESTEL analysis
  • Fig. 19 Neurology Clinical Trials Market: Phase outlook and key takeaways
  • Fig. 20 Neurology Clinical Trials Market: Phase movement analysis
  • Fig. 21 Phase I Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Phase II Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Phase III Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Phase IV Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Neurology Clinical Trials Market: Study design outlook and key takeaways
  • Fig. 26 Neurology Clinical Trials Market: Study design movement analysis
  • Fig. 27 Interventional Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Observational Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Expanded Access Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Neurology Clinical Trials Market: Indication outlook and key takeaways
  • Fig. 31 Neurology Clinical Trials Market: Indication movement analysis
  • Fig. 32 Alzheimer's Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Depression (MDD) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Parkinson's Disease (PD) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Epilepsy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Stroke Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Traumatic Brain Injury (TBI) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Amyotrophic Lateral Sclerosis (ALS) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Huntington's Disease Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Muscle Regeneration Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Neurology Clinical Trials Market: Indication by Study Design outlook and key takeaways
  • Fig. 43 Neurology Clinical Trials Market: Indication by Study Design movement analysis
  • Fig. 44 Alzheimer's Disease Interventional Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Alzheimer's Disease Observational Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Alzheimer's Disease Expanded Access Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Depression (MDD) Interventional Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Depression (MDD) Observational Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Depression (MDD) Expanded Access Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Parkinson's Disease (PD) Interventional Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Parkinson's Disease (PD) Observational Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Parkinson's Disease (PD) Expanded Access Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Epilepsy Interventional Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Epilepsy Observational Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Epilepsy Expanded Access Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Stroke Interventional Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Stroke Observational Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Stroke Expanded Access Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Traumatic Brain Injury (TBI) Interventional Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Traumatic Brain Injury (TBI) Observational Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Traumatic Brain Injury (TBI) Expanded Access Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Amyotrophic Lateral Sclerosis (ALS) Interventional Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Amyotrophic Lateral Sclerosis (ALS) Observational Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Amyotrophic Lateral Sclerosis (ALS) Expanded Access Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Huntington's Disease Interventional Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Huntington's Disease Observational Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Huntington's Disease Expanded Access Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Muscle Regeneration Interventional Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 Muscle Regeneration Observational Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Muscle Regeneration Expanded Access Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Others Interventional Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Others Observational Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 Others Expanded Access Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Neurology Clinical Trials Market: Value Chain Design outlook and key takeaways
  • Fig. 75 Neurology Clinical Trials Market: Value Chain movement analysis
  • Fig. 76 In-house Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 77 CROs Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 78 Investigator Sites/Clinical Sites Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 79 Regional Marketplace: Key Takeaways
  • Fig. 80 North America Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 81 Key country dynamics
  • Fig. 82 U.S. Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 83 Key country dynamics
  • Fig. 84 Canada Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 85 Key country dynamics
  • Fig. 86 Mexico Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 87 Europe Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 88 Key country dynamics
  • Fig. 89 UK Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 90 Key country dynamics
  • Fig. 91 Germany Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 92 Key country dynamics
  • Fig. 93 France Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 94 Key country dynamics
  • Fig. 95 Italy Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 96 Key country dynamics
  • Fig. 97 Spain Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 98 Key country dynamics
  • Fig. 99 Denmark Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 100 Key country dynamics
  • Fig. 101 Sweden Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 102 Key country dynamics
  • Fig. 103 Norway Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 104 Asia Pacific Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 105 Key country dynamics
  • Fig. 106 Japan Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 107 Key country dynamics
  • Fig. 108 China Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 109 Key country dynamics
  • Fig. 110 India Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 111 Key country dynamics
  • Fig. 112 Thailand Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 113 Key country dynamics
  • Fig. 114 South Korea Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 115 Key country dynamics
  • Fig. 116 Australia Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 117 Latin America Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 118 Key country dynamics
  • Fig. 119 Brazil Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 120 Key country dynamics
  • Fig. 121 Argentina Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 122 MEA Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 123 Key country dynamics
  • Fig. 124 South Africa Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 125 Key country dynamics
  • Fig. 126 Saudi Arabia Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 127 Key country dynamics
  • Fig. 128 UAE Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 129 Key country dynamics
  • Fig. 130 Kuwait Neurology Clinical Trials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 131 Key company categorization
  • Fig. 132 Service heat map analysis
  • Fig. 133 Strategic framework
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!